Over-expression of COX-2 mRNA in colorectal cancer

Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism

(2012) Beatriz Carvalho et al.   CELLULAR ONCOLOGY

Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue

(2011) F. Jahns et al.   CARCINOGENESIS

Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments?

(2010) J Caradec et al.   BRITISH JOURNAL OF CANCER

Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer

(2010) Y Hamaya et al.   BRITISH JOURNAL OF CANCER

Increased expression of cytoplasmic HuR in familial adenomatous polyposis

(2010) Lodewijk A.A. Brosens et al.   CANCER BIOLOGY & THERAPY

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

EGFR, HER-2 and COX-2 levels in colorectal cancer

(2008) A G Antonacopoulou et al.   HISTOPATHOLOGY

COX-2 mRna expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID

(2007) X. Liu et al.   DISEASES OF THE ESOPHAGUS